Journal article
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients with Tubercular Anterior Uveitis.
-
Agrawal R
Yong Loo Lin School of Medicine, National University of Singapore , Singapore, Singapore.
-
Betzler B
Yong Loo Lin School of Medicine, National University of Singapore , Singapore, Singapore.
-
Testi I
Moorfields Eye Hospital, NHS Foundation Trust , London, UK.
-
Mahajan S
Byres Eye Institute, Stanford University, Palo Alto , California, USA.
-
Agarwal A
Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.
-
Gunasekeran DV
National Healthcare Group Eye Institute, Tan Tock Seng Hospital , Singapore, Singapore.
-
Raje D
MDS Bioanalytics , Nagpur, India.
-
Aggarwal K
Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.
-
Murthy SI
Tej Kohli Cornea Institute, LV Prasad Eye Institute, Kallam Anji Reddy Campus , Hyderabad, India.
-
Westcott M
Moorfields Eye Hospital, NHS Foundation Trust , London, UK.
-
Chee SP
Yong Loo Lin School of Medicine, National University of Singapore , Singapore, Singapore.
-
Mccluskey P
Department of Clinical Ophthalmology & Eye Health, Central Clinical School, Save Sight Institute, the University of Sydney , Sydney, Australia.
-
Ho SL
National Healthcare Group Eye Institute, Tan Tock Seng Hospital , Singapore, Singapore.
-
Teoh S
National Healthcare Group Eye Institute, Tan Tock Seng Hospital , Singapore, Singapore.
-
Cimino L
Ocular Immunology Unit, Azienda USL IRCCS , Reggio Emilia, Italy.
-
Biswas J
Department of Ophthalmology, Sankara Nethralaya , Chennai, India.
-
Narain S
Department of Ophthalmology, Shroff Eye Centre , New Delhi, India.
-
Agarwal M
Department of Ophthalmology, Dr Shroff's Charity Eye Hospital Daryaganj , New Delhi, India.
-
Mahendradas P
Department of Uveitis and Ocular Immunology, Narayana Nethralaya , Bangalore, India.
-
Khairallah M
Department of Ophthalmology, Fattouma Bourguiba University Hospital, Faculty of Medicine, University of Monastir , Singapore, Singapore.
-
Jones N
Department of Ophthalmology, University of Manchester , Manchester, UK.
-
Tugal-Tutkun I
Istanbul Faculty of Medicine, Department of Ophthalmology, Istanbul University , Istanbul, Turkey.
-
Babu K
Prabha Eye Clinic & Research Centre, Vittala International Institute of Ophthalmology , Bangalore, India.
-
Basu S
Department of Ophthalmology, LV Prasad Eye Institute , Bhubaneswar, India.
-
Carreño E
Servicio de Oftalmología, Hospital Universitario Fundacion Jimenez Diaz , Madrid, Spain.
-
Lee R
Moorfields Eye Hospital, NHS Foundation Trust , London, UK.
-
Al-Dhibi H
Department of Ophthalmology, King Khaled Eye Specialist Hospital , Riyadh, Kingdom of Saudi Arabia.
-
Bodaghi B
DHU SightRestore, Department of Ophthalmology, Sorbonne University , Paris, France.
-
Invernizzi A
Eye Clinic, Department of Biomedical and Clinical Science "L. Sacco", Luigi Sacco Hospital, University of Milan , Milan, Italy.
-
Goldstein DA
Feinberg School of Medicine, Department of Ophthalmology, Northwestern University , Chicago, Illinois, USA.
-
Herbort CP
Centre for Ophthalmic Specialised Care & University of Lausanne , Lausanne, Switzerland.
-
Barisani-Asenbauer T
The Centre for Ocular Inflammation and Infection (OCUVAC), Laura Bassi Centre of Expertise Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna , Vienna, Austria.
-
González-López JJ
Department of Ophthalmology, Ramón y Cajal University Hospital , Madrid, Spain.
-
Androudi S
Department of Ophthalmology, University of Thessaly , Volos, Greece.
-
Bansal R
Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.
-
Moharana B
Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.
-
Esposti S
Moorfields Eye Hospital, NHS Foundation Trust , London, UK.
-
Tasiopoulou A
Moorfields Eye Hospital, NHS Foundation Trust , London, UK.
-
Nadarajah S
Moorfields Eye Hospital, NHS Foundation Trust , London, UK.
-
Agarwal M
Department of Ophthalmology, Sankara Nethralaya , Chennai, India.
-
Abraham S
Department of Ophthalmology, Sankara Nethralaya , Chennai, India.
-
Vala R
Department of Uveitis and Ocular Immunology, Narayana Nethralaya , Bangalore, India.
-
Singh R
Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.
-
Sharma A
Department of Rheumatology, PGIMER , Chandigarh, India.
-
Sharma K
Department of Microbiology, PGIMER , Chandigarh, India.
-
Zierhut M
Centre of Ophthalmology, Department of Ophthalmology, University of Tuebingen , Germany.
-
Kon OM
Chest and Allergy Clinic, St Mary's Hospital, Imperial College Healthcare NHS Trust , London, UK.
-
Cunningham ET
The Francis I. Proctor Foundation, UCSF School of Medicine , San Francisco, California, USA.
-
Kempen JH
Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School , Boston, Massachusetts, United States.
-
Nguyen QD
Byres Eye Institute, Stanford University, Palo Alto , California, USA.
-
Pavesio C
Moorfields Eye Hospital, NHS Foundation Trust , London, UK.
-
Gupta V
Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.
Show more…
Published in:
- Ocular immunology and inflammation. - 2020
English
PURPOSE
The Collaborative Ocular Tuberculosis Study (COTS) Group sought to address the diagnostic uncertainty through retrospective cohort analysis of treatment regimens and therapeutic outcomes for patients with tubercular Anterior Uveitis (TAU) across international centers.
METHODS
Multicentre retrospective analysis of patients diagnosed with TAU between January 2004 to December 2014 that had a minimum follow-up of 1 year.
RESULTS
One hundred and sixty-five patients were included. One hundred and seven subjects received antitubercular therapy (ATT) (n = 107/165; 64.9%) with all the patients receiving topical steroid therapy. Treatment failure was noted in 17 patients (n = 17/165; 10.3%), more frequently described in patients that received ATT (n = 13/107, 12.2%), than those that did not receive ATT (n = 4/58, 6.9%).
CONCLUSION
In this retrospective study, addition of ATT did not have any statistically significant impact on outcome in patients with TAU.
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/149015
Statistics
Document views: 15
File downloads: